Earnings Feed
Start Free
Regulus Therapeutics Inc.·4

Jun 18, 5:00 PM ET

Collier Kathryn J 4

4 · Regulus Therapeutics Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-16
Regulus Therapeutics Inc.RGLS
Collier Kathryn J
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-17$9.90/sh+2,604$25,780→ 65,240 total
  • Exercise/Conversion

    Common Stock

    2025-06-16$9.90/sh+1,396$13,820→ 67,844 total
  • Exercise/Conversion

    Common Stock

    2025-06-17$8.80/sh+2,325$20,460→ 62,915 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-06-17−2,325→ 0 total
    Exercise: $8.80From: 2021-06-14Exp: 2030-06-16→ Common Stock (2,325 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-06-16−1,396→ 2,604 total
    Exercise: $9.90From: 2022-06-09Exp: 2031-06-13→ Common Stock (1,396 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-06-17−2,604→ 0 total
    Exercise: $9.90From: 2022-06-09Exp: 2031-06-13→ Common Stock (2,604 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary

    4